{
    "source": {
        "id": "al-jazeera-english",
        "name": "Al Jazeera English"
    },
    "author": "Radmilla Suleymanova",
    "title": "Stocks end mixed after coronavirus drug did not improve patients - Al Jazeera America",
    "description": "<ol><li>Stocks end mixed after coronavirus drug did not improve patients\u00a0\u00a0Al Jazeera America\r\n</li><li>Wall Street clings to early gains despite dismal PMI data\u00a0\u00a0FXStreet\r\n</li><li>The close: TSX, S&P 500 slip after report on coronavirus drug trial\u00a0\u00a0The Globe\u2026",
    "url": "https://www.aljazeera.com/ajimpact/tug-war-wall-street-dreadful-jobless-data-200423122126930.html",
    "urlToImage": "https://www.aljazeera.com/mritems/Images/2020/4/23/e2c90476e5604167898ea2c14e794e46_18.jpg",
    "publishedAt": "2020-04-23T20:39:00Z",
    "content": "The S&amp;P 500 ended marginally lower on Thursday after a report that an experimental antiviral drug for the coronavirus flopped in its first randomised clinical trial, denting earlier optimism that the impact of the pandemic on the United States labour mark\u2026 [+2845 chars]"
}